eNVi-SR
Commercial- Indications
- Ischemic stroke
Company intelligence / Profile preview
NeuroVasc Technologies develops novel catheter-based neurovascular devices for treating stroke and other neurovascular conditions. The company holds at least 14 patents related to embolus removal and blood flow restriction devices. Its technologies are designed to facilitate broad treatment options for patients suffering from acute ischemic stroke and similar neurological conditions. No published clinical trial results were found in the provided sources; however, their products are implied to be commercially available or close to commercialization based on patent grants and industry activity.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeuroVasc Technologies.